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Abstract 
The pKa value of the α-phosphate moiety of uridine 5’-diphosphate-GlcNAc (UDP-GlcNAc) has 
been successfully calculated using density functional theory methods in conjunction with the 
Polarizable Continuum Models. Theoretical methods were benchmarked over a dataset comprising of 
alkyl phosphates. B3LYP/6-31+G(d,p) calculations using SMD solvation model provide excellent 
agreement with the experimental data. The predicted pKa for UDP-GlcNAc is consistent with most 
recent NMR studies but much higher than what it has long been thought to be. The importance of 
this study is evident that the predicted pKa for UDP-GlcNAc supports its potential role as a catalytic 
base in the substrate-assisted biocatalysis. 
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1. Introduction 
The modification of serines and threonines on nuclear and cytoplasmic proteins with O-linked β-D-
N-acetylglucosamine (O-GlcNAc) is known as O-GlcNAcylation1,2. Two enzymes are mainly 
involved in the regulation of O-GlcNAcylation: a glycoside transferase called O-GlcNAc transferase 
(OGT) and a glycoside hydrolase called O-GlcNAcase (OGA)3-5. OGT installs O-GlcNAc from the 
donor UDP-GlcNAc at the sites of modification and OGA removes the modification6. O-GlcNAc 
modification is associated with various biological processes including transcription and translation. 
Apart from cell signalling, faulty regulation of O-GlcNAc may also be involved in diseases such as 
diabetes mellitus, neurodegenerative diseases and cancers7,8. Recent studies have also reported the 
importance of O-GlcNAc signalling in the immune system9.  
Considering the importance of UDP-GlcNAc and its key role in acting as the substrate for several 
enzymes including OGT3-5,10, UDP-GlcNAc 2-epimerase11 and UDP-GlcNAc enolpyruvyl 
transferase (MurA)12, an accurate prediction of the structure and reactivities of UDP-GlcNAc and its 
analogues could prove to be vital in understanding many biochemical reactions. Particularly, the pKa 
of the α-phosphate in UDP-GlcNAc has been debated in the literature5,13. It has long been thought to 
be around 2-3 in both UDP and UDP-GlcNAc10,13. Based on this, a substrate-assisted catalytic 
mechanism in which UDP-GlcNAc functions as a general base to deprotonate the Serine side chain 
in the substrate in OGT has been explicitly ruled out due to the expected unfavourable energetics4,5,10 
(Figure S1b).  Only recently, Jancan and Macnaughtan have first reported a 31P-NMR titration of 
UDP-GlcNAc and shown that the pKa of the α-phosphate in UDP-GlcNAc is around 6.5, which 
makes it suitable as a general base in OGT14. In contrast, the popular empirical pKa predictor 
Marvin15 predicted its pKa to be 3.3. In order to completely understand the catalysis in such 
reactions, a detailed analysis of its pKa and potential pKa shifts in the enzymatic active site is 
required.  
To address this problem, we aimed at establishing a rational and well-calibrated method that could 
predict the absolute pKa value for UDP, UDP-GlcNAc and their analogues. Systematic 
benchmarking calculations on a set of alkyl phosphates with known experimental pKa values were 
performed to validate the theoretical models. By comparing the predicted pKa’s from various 
methods to their experimental values, we try to find an optimal combination of methods for gas 
phase geometry, implicit solvation model for solvation free energies and the proton solvation free 
energy16,17. The predicted pKa of UDP-GlcNAc was in accordance with the literature findings, 
supporting its general base nature. 
 
2. Theoretical Calculation of pKa 
Continuum solvent pKa calculations using direct method utilize a thermodynamic cycle (Figure 1), 
which combines gas-phase acidity with solvation free energies obtained from various models.  
[Insert Figure 1] 
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The directly calculated pKas may be obtained through Eq (1) 
p"# =
%&'(∗
*+,-	(01)                                                                             (1) 
ΔG56∗ 	is defined as the difference in the free energies in solution between the acid (HA) and the 
conjugate base (A-) and the free proton (H+). For computational efficiency,	ΔG56∗  can be obtained 
through the thermodynamic cycle defined in Figure 1 using Eq. 2-5, 
	ΔG56∗ = ΔG758∗ + ΔΔG8:,;∗                                                              (2) 
		ΔΔG8:,;∗ = ΔG8:,;∗ (H=) + ΔG8:,;∗ (A?) − ΔG8:,;∗ (HA)                                       (3) 
ΔG758A = G7A(H=) + G7A(A?) − G7A(HA)                                                 (4) 
ΔG758∗ = ΔG758A + Δn758RT	ln	(RT)                                              (5) 
where the symbol ΔG∗ denotes Gibbs free energy referred to a standard state of 1 mol L-1 as opposed 
to ΔG: referring to a standard state of 1 atm for each species. R and R are the gas constant in units of 
J mol-1 K-1 and L atm mol-1 K-1, respectively. Often, ΔG8:,;∗  (H+) is taken from the experimental 
solvation free energy of the proton. Its value has been extensively discussed in the literature16-18 and 
we have used ΔG8:,;∗  (H+) of -1112.5 kJ/mol, recommended by Tissandier et.al19 based on their 
cluster-pair-based method. The two standard states for the gas-phase reaction free energies are 
related by Eq. (5) where G758:  (H+) is -26.4 kJ/mol.  
 
3. Computational Methodology 
To calculate the absolute pKa value of UDP-GlcNAc, we benchmarked with a dataset of alkyl 
phosphates with known experimental pKa (Figure 2, their optimised structures are provided in 
Supporting Material). All the gas and solvent phase ab initio calculations were performed using 
Gaussian0320 or Gaussian0921. There is no standard methodology in the literature considered best for 
the calculation of pKa for this class of molecules. Hence a rigorous benchmark against experimental 
data is highly desirable to make reliable predictions. The complete basis set method (CBS-QB3) 
developed by Petersson and co-workers22 and density functional theory (DFT) methods were used to 
obtain accurate gas phase energies in Eq (4). The hybrid exchange-correlation functional of Becke, 
Lee, Yang, and Parr (B3LYP)23 and the hybrid functional of Zhao and Truhlar (M06-2X)24, were 
used for the DFT calculations, with two standard basis sets 6-31+G(d,p) and 6-311++G(d, p). The 
motivation for adopting DFT calculations is that CBS-QB3 is computationally prohibitive for UDP 
and UDP-GlcNAc in routine calculations. After validating the theoretical methods using the dataset 
of compounds at varying levels of theory, the estimation of pKa for UDP-GlcNAc was performed. 
[Insert Figure 2] 
Comparatively speaking, it has been shown in previous studies that the major error source in 
calculating pKas according to Figure 1 is from the solvation free energy calculations25,26. To identify 
an appropriate solvation model for our calculations, the solvation free energies were computed at 
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recommended levels of theory using various solvation models16,18,27. The conductor-polarizable 
continuum model (CPCM)28 was applied at the B3LYP/6-31+G(d) and HF/6-31+G(d) levels of 
theory with the united atom (UA) cavity models, UAKS and UAHF using Gaussian03. We have also 
computed solvation free energies using SMD solvation model by Truhlar and co-workers29, which 
uses the Polarizable Continuum Model (PCM) with the integral equation formalism variant using 
UFF radii (IEFPCM) using Gaussian 09. The SMD model is optimized with both B3LYP and M06-
2X functionals. Using the thermodynamic cycle (Figure 1) and various combinations of 
ΔG758∗ 	and	ΔΔG8:,;∗  values, the pKas for each compound in its gas-phase energy minima were 
calculated. For solvent phase calculations with the SMD model, single point energy calculations 
were performed on the gas-phase optimized geometries. For the UAKS and UAHF models, geometry 
optimisations were carried out starting from the gas phase optimised geometries. Takano and Houk30 
have earlier demonstrated based on their benchmarking studies of CPCM models on a dataset of 70 
organic molecules (30 neutral, 21 anions and 19 cations) that geometries optimized in gas phase and 
in water were rather similar. Considering other competitive mechanisms proposed in the literature for 
OGT (Figure S1), the pKas for other potential catalytic bases including Histidine 498 (His)4 and 
Aspartic acid 554 (Asp) 5,10,31 were calculated as well. In these calculations, both His and Asp were 
capped with acetylated N-terminus (ACE) and N-Methylamide C-terminus (CT3).  
Table 1 should be used as a key to classify the level of theory used to obtain ΔG758∗ 	and	ΔΔG8:,;∗  
values in this paper. For example, G1/S1 notation indicates the gas-phase calculations evaluated at 
CBS-QB3 level of theory and the solvation free energies obtained at B3LYP/6-31+G (d) level of 
theory using SMD model. 
[Insert Table 1] 
There are also several empirical pKa prediction tools available32, which are found to predict rather 
accurate pKa values including Epik (Schördinger, New York, USA), Marvin (Chemaxon, Budapest, 
Hungary), ACD pKa DB (ACDLabs, Toronto, Canada). These methods are fast and cost-effective for 
the primary evaluation of ionization constants. Hence, as a next step we calculated the pKa for our 
dataset using the pKa prediction tool available in the Chemaxon’s Marvin interface15, which is based 
on the Hammett-Taft approach33. Marvin estimates the pKa, based on the sum of the partial charge 
increment, structure specific and polarizable increments from the ionization site-specific regression 
equations. 
 
4. Source of Error and Definition of Acceptable Margin 
There are various factors contributing to error during the calculation of pKa using the direct method. 
Aqueous reaction free energies of deprotonation as calculated by the cycle in Figure 1 are dependent 
on two components, ΔΔG8:,;∗  and ΔG758A . Computing gas-phase acidities is reasonably straightforward 
due to the absence of environmental effects17.  
Based on the studies by Ho and Coote on a dataset comprising of carbon acids, gas-phase reaction 
energies were found to have an uncertainty of ~4.2 kJ/mol while errors in continuum solvent 
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calculations to be around 4.2 and 16.7 kJ/mol from various benchmarking studies16,19,34-36. Takano 
and Houk have suggested a mean absolute deviation (MAD) of ~10 kJ/mol by comparing the 
aqueous solvation free energies calculated by CPCM model on a dataset of 70 organic molecules to 
their experimental data30. Based on their parameterisation of the PCM model to calculate anionic 
solvation free energies in an aqueous solution, Pliego and Riveros25 have reported an error of ~5 
kJ/mol.   
The use of an experimental solvation free energy of the proton, i.e., ΔG8:,;∗  (H+) = -1112.5 kJ/mol, 
also contributes an error of around ~10 kJ/mol34. However, pKa calculations by direct method with 
this ΔG*solv (H+) were able to reproduce experimental values within an acceptable error margin37-40. 
In comparison with various protocols used by different groups in pKa calculations in earlier studies, 
an acceptable error margin for a directly calculated pKa was defined, which should be in the vicinity 
of 3.5 pKa units, a relatively large range according to the benchmarking studies of Ho and Coote16. 
 
5. Results and Discussion 
5.1. Gas-phase Acidities 
In previous benchmarking studies, where the gas-phase experimental data was not available, the 
CBS-QB3 ΔG758A  values were used as the reference41. The CBS-QB3 was well established to predict 
accurate ΔG758A  values, which are used in various studies reporting the calculated pKa for 
benchmarking18,22. The results are summarized in Table S1 and Figure S2. Overall comparison 
suggests that the gas-phase data obtained from DFT (G2, G3, G4, G5) methods had a MAD of 4.5 - 
6.5 kJ/mol compared to the results from CBS-QB3, with G5 being the closest. Addition of an extra 
diffusion function in DFT based calculations (G2, G4 vs. G3, G5) didn’t improve the computational 
ΔG758A  accuracy significantly. We have achieved higher accuracy when comparing with previous 
benchmarking studies on a dataset comprising of 46 acids and 30 bases by Burk et al. where, 
B3LYP/6-311++G(d,p) predicted gas-phase acidities and basicities with an average accuracy of <13 
kJ/mol and that of < 20 kJ/mol for B3LYP/6-31+G(d)42. The gas-phase calculation for UDP and 
UDP-GlcNAc was prohibitive with larger basis sets (G1, G2, G4) due to unaffordable computational 
cost. 
5.2. Solvation Free Energies 
All the solvent-phase calculations with SMD model were carried out on the gas-phase optimized 
geometries while the calculations with CPCM (UAHF and UAKS radii) models used solution 
optimized geometries. From the solvent-phase calculations, it was observed that each of the PCM 
models used would predict the solvation free energies with a considerable variation and thus 
influence the pKa values significantly. Both the CPCM models (UAHF and UAKS) contributed to 
the highest values obtained in each case, while the smallest values were with the SMD model (Table 
S2 and Figure S3).   
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In recent study by Ho and Ertem36, a different value of ΔG8:,;∗  (H+) = -1093.7 kJ/mol was used for the 
CPCM-UAHF model, as it was the parameterized value for this particular solvation model28. So to 
see if it would improve our results any further, we calculated the solvation free energies using this 
parameterized value for CPCM-UAHF calculations alone. Using this value didn’t improve our 
results, when the pKa was calculated using these solvation free energies, the MAD increased by 2.2 
pKa units compared to our earlier results using the CPCM-UAHF model with ΔG8:,;∗  (H+) of -1112.5 
kJ/mol recommended by Tissandier et.al19. From these calculations it was evident that having an 
accurate ΔG*solv (H+) influences the predicted pKa significantly. 
5.3. Predicated pKa Values 
pKa values have been calculated by combining theoretical gas-phase acidities with the solvation free 
energies obtained from three solvent models. The calculated pKa values with SMD model using 
direct method for the dataset, along with the experimental data43,44, are presented in Table 2. The 
remaining pKa values obtained by CPCM (UAHF and UAKS radii) models are provided in Tables S1 
and S2 in the supplementary material. 
[Insert Table 2] 
Analysis of the pKa values from Tables 2, S1 and S2 reveal that more accurate pKa values were 
obtained using the SMD model, than those with the CPCM models. In case of G1/S1 and G3/S1 
using SMD model, the MADs are within 1 pKa unit. All the pKas predicted by G5/S2 indicates a 
systematic underestimation with a MAD of 1.2 units. The results from G1/S1 are overestimated by a 
MAD value of 0.7 units. Comparatively the best results were produced using G3/S1 with a MAD 
value of 0.4 units (Figure 3). 
[Insert Figure 3] 
It is well known that the performance of the CPCM models is limited to the restricted functional 
groups used in the parameterization26,28. Although the CPCM-UAHF/UAKS models have given 
accurate pKa values previously, severe stability problems and larger deviations were also reported in 
earlier studies and they might not suit other systems like ours16,45.  Previously Rayne and Forest27 
have demonstrated that CPCM-UAHF/UAKS models underestimated the solvation free energies by 
~25 to 71 kJ/mol based on their parameterization of a dataset made up of perfluorinated alkyl 
compounds. Our results also show that these two models lead to relatively larger errors regardless of 
the gas-phase theories used. These larger deviations might be due to how these solvent models have 
been parameterized to a particular dataset.  
From the benchmarking studies, it is evident that the SMD model gives best pKa values of alkyl 
phosphates which might result from the use of an accurate atomic radius and the fact that most 
studied compounds have similar functional groups26.  
5.4. pKa Calculations with Marvin and PM6 for the Dataset 
Marvin was used to predict the pKa for the dataset using the inbuilt pKa prediction tool plugin. The 
predicted results were very accurate with a MAD of 0.5 (Table 2), which was better than a few of the 
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ab initio models we have used. Interestingly though major part of the MAD was contributed by 
phosphopyruvic acid, with an absolute deviation of 2.7 pKa units. These results were also in 
agreement with the previous comparative studies by Balogh et al46. According to their comparative 
evaluation of various empirical pKa prediction tools, Marvin was found to outperform the other 
similar tools in terms of accuracy, which was one of the main factors for choosing it for our 
benchmarking studies.  
Recently it has been shown that PM6 provides a satisfactory prediction for a dataset comprising of 
pyridines, alcohols, phenols, benzoic acids, carboxylic acids, and phenols with the so-called 
isodesmic model47 (Figure S4). We carried out additional pKa calculations with the isodesmic and 
direct methods using PM6 level of theory. The results show that, though PM6/SMD provided a 
satisfactory prediction for the isodesmic method with a MAD of 0.7 pKa units, it failed to provide a 
reasonable prediction with the direct method, which resulted in a MAD of 14.8 pKa units (See 
Supplementary data).  
5.5. pKa Calculation of UDP and UDP-GlcNAc 
As the computational method with acceptable accuracy has been validated, we used G3/S1 along 
with Marvin to predict the pKa of UDP and UDP-GlcNAc (Table 3). The pKa was calculated for the 
deprotonation of both α-phosphate and β-phosphate moieties of UDP. The predicted pKa values using 
G3/S1 for UDP were found to be close to the experimental data14, with each exhibiting a deviation of 
0.6 and 1.0 units respectively, whereas Marvin significantly underestimated the pKa for both with an 
absolute deviation of 3.3 and 4.7 respectively.  
[Insert Table 3] 
The G3/S1 combination predicted the pKa of UDP-GlcNAc to be around 6.9, which is very close to 
the experimental value by Jancan and Macnaughtan14 with an absolute deviation of 0.3 units. Marvin 
predicted it to be 3.0, with an absolute deviation of 3.6. The significant underestimation of Marvin 
might be due to the mid range effect reported by Balogh et al.46 According to their study, empirical 
tools including Marvin have a limitation for compounds with a mid-range pKa value (pKa around 6) 
and for weak acids (pKa around 12). They have reported a mean absolute error of 2 pKa units for 
compounds at pKa ~6 which is consistent with our findings. This also highlighted the necessity to use 
validated quantum chemistry methods to study the complex chemistry of phosphate.  
5.6. pKa Calculation of Amino Acids as the Potential Alternative Base in OGT 
Next we tried to verify, if this method could be extended to provide an accurate pKa for the side 
chains of amino acids that potentially serve as a general base in OGT. His and Asp were considered, 
as they have also been proposed to be the catalytic base in the catalysis of OGT4,5,10,31 (Figure S1a 
and S1c). The reaction used for the calculation of pKa of His and Asp can be seen in Figure 4. 
[Insert Figure 4] 
The pKa of His calculated using G3/S1 model is comparable to the experimental value (6.0)48 with an 
absolute deviation of 0.8 units. This is a better agreement comparing to the study by Sastre et al in 
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which an isodesmic reaction scheme with PM6 was used49. Whereas for Asp the calculated pKa was 
not so accurate with a significant deviation of 3.0 units from the experimental value (3.7)48, which is 
1.1 units larger than that reported in Ref 49 (Table 4). While the pKa calculation for His is 
encouraging, the Asp result shows that a specific model cannot be universally applied to different set 
of compounds. From the above benchmarking studies, we believe that despite a lack of universality, 
the G3/S1 (B3LYP/6-31+G(d,p)//B3LYP/6-31+G(d) (SMD)) model can predict accurate pKa for 
phosphate related compounds having a similar functional group. 
[Insert Table 4] 
6. Conclusions 
The present benchmarking study assesses the ability of various gas-phase and solvent-phase models 
to reproduce the experimental pKa of a series of alkyl-phosphates. The CBS-QB3 and DFT methods 
were investigated along with various solvation models. The calculated gas-phase deprotonation 
energies and free energies of solvation were compared, and the errors associated with each method 
were estimated. It was found that B3LYP/6-31+G(d,p) together with the SMD solvation model is 
more accurate compared to CPCM-UAHF and CPCM-UAKS models for our dataset. This model 
was used to evaluate the absolute pKa value of UDP-GlcNAc. It successfully reproduced the 31P-
NMR experimental data to within 0.3 pKa units. Future work will be carried out to characterize the 
pKa values of UPD-GlcNAc analogues and their apparent pKa values (and thus pKa shifts) within a 
protein environment50-52, with the aim to establish the relevant catalytic mechanism in OGT. 
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Table 1. Quantum chemical calculations used in computations of gas-phase and solvent-phase 
calculations given in shorthand notation used in the text 
Gas-Phase Calculations Solvent-Phase Calculations 
Label Level of Theory Basis Set Label Level of Theory Basis Set Solvation Model 
G1 CBS-QB3 	 S1 DFT-B3LYP 6-31+G (d) SMD 
G2 DFT-B3LYP 6-311++G (d, p) S2 DFT-M06-2X 6-31+G (d) SMD 
G3 DFT-B3LYP 6-31+G (d, p) S3 RHF 6-31+G (d) CPCM-UAHF 
G4 DFT-M06-2X 6-311++G (d, p) S4 DFT-B3LYP 6-31+G (d) CPCM-UAKS 
G5 DFT-M06-2X 6-31+G (d, p) 	 	 	 	
 
Table 2. Calculated pKa of the dataset with SMD model using different gas-phase energies and 
solvation energies 
 Alkyl Phosphate Name 
Experi-
mental 
pKa 
G1/S1 Abs. Dev. G3/S1 
Abs. 
Dev. G5/S2 
Abs. 
Dev. Marvin  
Abs. 
Dev. 	
	
Methyl Phosphate 1.5a 2.0 0.5 0.7 0.8 0.7 0.8 1.8 0.3 	
Ethyl Phosphate 1.6a 2.2 0.6 1.6 0.0 1.1 0.5 1.8 0.2 	
n-propyl Phosphate 1.8a 2.0 0.2 1.2 0.6 0.8 1.0 1.8 0.0 	
n-butyl Phosphate 1.8a 2.9 1.1 1.8 0.0 1.2 0.6 1.8 0.1 	
Dimethyl Phosphate 1.3a 1.7 0.4 1.0 0.3 0.3 1.0 2.0 0.7 	
Di-n-propyl Phosphate 1.6a 2.7 1.1 1.7 0.1 1.2 0.4 1.9 0.4 	
Di-n-Butyl Phosphate 1.7a 2.8 1.1 1.9 0.2 1.0 0.7 1.9 0.2 	
Glyceraldehyde Phosphate 2.1b 2.3 0.2 1.7 0.4 0.4 1.7 1.4 0.7 	
3-phosphoglyceric acid 1.4b 1.8 0.4 0.8 0.6 -0.1 1.5 1.3 0.1 	
Phosphopyruvic acid 3.5b 1.8 1.7 2.3 1.1 -0.5 4.0 0.8 2.7 	
a Ref. 43. b Ref. 44. 
 
 
Table 3. Calculated pKa of UDP and UDP-GlcNAc  
Analogue Name Experimental pKa G3/S1 Abs. Dev. Marvin Abs. Dev. 
UDP α-Phosphate 6.5a 5.9 0.6 3.2 3.3 
UDP β-Phosphate 6.5a 5.5 1.0 1.8 4.7 
UDP-GlcNAc 6.6a 6.9 0.3 3.0 3.6 
a Ref. 14. 
 
 
 
 
 
Table 4. Calculated pKa of Histidine and Aspartic Acid 
Amino acid Experimental pKa 
G3/S1 Abs. Dev. Theoretical pKa reported by Sastre et al ΔpKab 
Histidine 6.0a 6.8 0.8 0.9 
Aspartic acid 3.7a 6.6 3.0 1.9 
a Ref.  48.  b Ref. 49. 
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